(NRO) Neurones - Ratings and Ratios
Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0004050250
NRO: Infrastructure, Application, Consulting, Cloud, Cybersecurity, Automation, IT
Neurones S.A. operates as a multifaceted IT services company, delivering a broad range of solutions that cater to the diverse needs of its clients across France and international markets. The company's infrastructure services encompass a wide array of offerings, including infrastructure management, public and private cloud services management, IT operations, user support, DevOps, cybersecurity, IT service management, information system governance, and automation. This comprehensive suite of services enables organizations to optimize their IT infrastructure, enhance operational efficiency, and ensure the security and integrity of their data.
Neurones S.A. also provides an extensive portfolio of application services, which include expertise in SAP, digital transformation, web development, mobility solutions, UX/UI design, enterprise content and document management, business process management, robotic process automation, dematerialization, and IT consulting for finance, big data, and DevOps. Additionally, the company offers IT training and change management services, as well as innovation connected devices (IoT) solutions, to help organizations navigate the complexities of digital transformation and stay ahead of the curve in terms of technology adoption and innovation.
The company's consulting services are designed to support clients in their digital transformation journeys, with a focus on management and digital transformation, digital marketing consulting, and a range of specialized services. These include agile/scrum, DevOps, CI/CD, cloud, infrastructure as code, cybersecurity, analytics, big data, mobility, digital workplace, connected devices, innovations, client experience, UX/UI, and digital marketing. Furthermore, Neurones S.A. provides internal process digitization services, including ECM/BPM, RPA, dematerialization, AI, predictive maintenance, machine learning, and blockchain, to help organizations streamline their operations, improve efficiency, and reduce costs.
Neurones S.A. serves a diverse range of markets, including banking and insurance, services and consumer goods, energy, utilities, and healthcare, technologies, media, and telecoms, industry, public works, and civil engineering, as well as the public sector. With a history dating back to 1984, the company has established itself as a trusted partner for organizations seeking to leverage IT services to drive business growth, improve competitiveness, and achieve their strategic objectives. Headquartered in Nanterre, France, Neurones S.A. is listed on the stock exchange with the ISIN FR0004050250 and is classified as a common stock under the GICS Sub Industry of IT Consulting & Other Services.
Additional Sources for NRO Stock
NRO Stock Overview
Market Cap in USD | 1,113m |
Sector | Technology |
Industry | Information Technology Services |
GiC Sub-Industry | IT Consulting & Other Services |
IPO / Inception |
NRO Stock Ratings
Growth 5y | 82.6% |
Fundamental | 69.8% |
Dividend | 59.7% |
Rel. Strength Industry | -88.9 |
Analysts | - |
Fair Price Momentum | 44.73 EUR |
Fair Price DCF | 68.23 EUR |
NRO Dividends
Dividend Yield 12m | 2.74% |
Yield on Cost 5y | 6.43% |
Annual Growth 5y | 43.10% |
Payout Consistency | 89.2% |
NRO Growth Ratios
Growth Correlation 3m | -83.7% |
Growth Correlation 12m | 9.1% |
Growth Correlation 5y | 96.3% |
CAGR 5y | 18.23% |
CAGR/Mean DD 5y | 2.69 |
Sharpe Ratio 12m | -0.09 |
Alpha | -15.36 |
Beta | 0.53 |
Volatility | 25.93% |
Current Volume | 1.5k |
Average Volume 20d | 4.1k |
As of January 22, 2025, the stock is trading at EUR 43.85 with a total of 1,521 shares traded.
Over the past week, the price has changed by +0.23%, over one month by +0.23%, over three months by -6.62% and over the past year by +1.91%.
Yes, based on ValueRay Fundamental Analyses, Neurones (PA:NRO) is currently (January 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 69.82 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NRO as of January 2025 is 44.73. This means that NRO is currently overvalued and has a potential downside of 2.01%.
Neurones has no consensus analysts rating.
According to ValueRays Forecast Model, NRO Neurones will be worth about 48.9 in January 2026. The stock is currently trading at 43.85. This means that the stock has a potential upside of +11.58%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 50 | 14% |
Analysts Target Price | - | - |
ValueRay Target Price | 48.9 | 11.6% |